Global Healthcare Exchange (GHX) (Louisville, CO) announced it acquired Lumere (Chicago, IL), a provider of evidence-based data and an
alytics solutions that enable healthcare organizations to build clinically integrated supply chains and optimize medication formulary management.
GHX believes the acquisition will allow it to “create the gold standard in data governance, providing a single source of trusted information for the management of devices and drugs used in the delivery of care.”
The Lumere acquisition also significantly extends GHX’s footprint in the pharmaceutical market, helping health systems more strategically manage the complex area of pharmacy cost. Key Lumere leaders, including CEO Hani Elias, CTO Will Danford, and president/chief strategy officer Eric Meizlish will remain with the combined organization. Financial terms of the deal were not disclosed.